Human MxA is a potent interspecies barrier for the novel bat-derived influenza A-like virus H18N11. Issue 1 (1st January 2019)

• Record Type: Journal Article
• Authors: Ciminski, Kevin; Pulvermüller, Johanna; Adam, Julia; Schwemmle, Martin
• Is Part Of: Emerging microbes & infections. Volume 8:Issue 1(2019)
• Page Start: 556
• Page End: 563
• Publication Date: 2019-01-01
• Subjects: Bat influenza A virus -- H18N11 -- chimeric influenza A virus -- PR8-H18N11 -- MxA -- interspecies barrier -- zoonotic spill-over; Medical microbiology -- Periodicals; Communicable diseases -- Periodicals; Infection -- Periodicals; 616.9041
• DOI: 10.1080/22221751.2019.1599301
• Languages: English
• ISSNs: 2222-1751

Abstract

ABSTRACT: The human innate immune factor MxA represents an effective interspecies barrier for zoonotic influenza A viruses (IAVs) of animal origin. Accordingly, human but not avian IAVs efficiently escape the antiviral activity of MxA due to adaptive mutations in their viral nucleoprotein. Partial MxA resistance can be acquired in intermediate hosts such as swine, which possess an antivirally active Mx1 protein. Intriguingly, Mx1 of the bat Carollia perspicillata, a host of the recently discovered bat influenza A-like virus H18N11, is antivirally active against avian IAVs, thus raising the question whether H18N11 has undergone a preadaptation to human MxA. Here, by utilizing a chimeric bat influenza virus, PR8-H18N11, we demonstrate that MxA efficiently blocks viral replication in vitro as well as in MxA transgenic mice. Nevertheless, the H18N11 nucleoprotein exhibits partial MxA resistance in a polymerase reconstitution assay, suggesting that a certain degree of MxA preadaptation occurred. Together, our data indicate a currently reduced risk for H18N11 to overcome the human restriction factor MxA. Further adaptive mutations in NP are required to facilitate full MxA escape.